MarketCap
Facebook
X
Telegram
Tenax Therapeutics Total Current Liabilities | TENX
Annual Total Current Liabilities Tenax Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 1967 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.16 M | 4.69 M | 3.59 M | 1.85 M | 1.56 M | 2.12 M | 2.53 M | 1.57 M | 1.01 M | 6.2 M | 4.6 M | 2.57 M | 1.91 M | 3.13 M | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 7.16 M | 1.01 M | 3.18 M |
Total Current Liabilities of other stocks in the Biotechnology industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Институт стволовых клеток человека
ISKJ
|
556 M | - | - | - |  Russia |
 |
Lyra Therapeutics
LYRA
|
9.52 M | - | - | $ 24.9 M |  USA |
 |
Завод ДИОД
DIOD
|
105 M | - | - | - | Russia |
 |
Фармсинтез
LIFE
|
1.02 B | - | - | - | Russia |
 |
Brickell Biotech
BBI
|
1.66 M | - | -5.38 % | $ 6.06 M | USA |
 |
Applied Therapeutics
APLT
|
27.3 M | - | - | $ 8.42 M | USA |
 |
ESSA Pharma
EPIX
|
3.3 M | - | - | $ 8.86 M |  Canada |
 |
Generation Bio Co.
GBIO
|
35.1 M | - | - | $ 344 M | USA |
 |
Clearside Biomedical
CLSD
|
4.79 M | - | - | $ 25.3 M | USA |
 |
Merus N.V.
MRUS
|
87.1 M | - | - | $ 5.78 B |  Niderland |
 |
RAPT Therapeutics
RAPT
|
48.4 M | - | - | $ 2.36 B | USA |
 |
Exicure
XCUR
|
3.89 M | $ 1.09 | 3.81 % | $ 6.86 M | USA |
 |
AbCellera Biologics
ABCL
|
64.3 M | $ 12.03 | 1.78 % | $ 3.59 B | Canada |
 |
Arrowhead Pharmaceuticals
ARWR
|
195 M | $ 58.93 | 1.57 % | $ 7.88 B | USA |
 |
BioMarin Pharmaceutical
BMRN
|
759 M | $ 55.62 | -0.59 % | $ 10.7 B | USA |
 |
Celldex Therapeutics
CLDX
|
51 M | $ 29.48 | 0.79 % | $ 1.96 B | USA |
 |
CollPlant Biotechnologies Ltd.
CLGN
|
2.67 M | $ 3.75 | 2.18 % | $ 45.8 M |  Israel |
 |
Jaguar Health
JAGX
|
40.7 M | $ 2.36 | 15.44 % | $ 5.5 M | USA |
 |
Protalix BioTherapeutics
PLX
|
26.5 M | $ 2.49 | -2.35 % | $ 196 M | Israel |
 |
uniQure N.V.
QURE
|
62.9 M | $ 21.65 | -3.5 % | $ 1.24 B | Niderland |
 |
Stoke Therapeutics
STOK
|
57.9 M | $ 25.41 | 1.48 % | $ 1.5 B | USA |
 |
Xencor
XNCR
|
95.9 M | $ 29.2 | 15.95 % | $ 2.17 B | USA |
 |
Annexon
ANNX
|
42.6 M | $ 3.71 | -1.2 % | $ 575 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
2.73 M | $ 1.71 | -4.21 % | $ 2.82 M | Israel |
 |
Incyte Corporation
INCY
|
1.52 B | $ 113.3 | -2.08 % | $ 22.1 B | USA |
 |
MeiraGTx Holdings plc
MGTX
|
123 M | $ 9.2 | -0.16 % | $ 740 M | USA |
 |
Vertex Pharmaceuticals Incorporated
VRTX
|
3.86 B | $ 516.39 | -1.44 % | $ 132 B | USA |
 |
Catalyst Biosciences
CBIO
|
18.3 M | $ 12.77 | -0.39 % | $ 1.14 B | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
158 M | $ 25.47 | 1.29 % | $ 1.19 B | USA |
 |
Anika Therapeutics
ANIK
|
21.9 M | $ 21.19 | -1.07 % | $ 304 M | USA |
 |
Editas Medicine
EDIT
|
46.2 M | $ 2.4 | 0.05 % | $ 213 M | USA |
 |
EyePoint Pharmaceuticals
EYPT
|
37 M | $ 0.36 | -10.09 % | $ 26.4 K | USA |
 |
Fortress Biotech
FBIO
|
49.7 M | $ 1.87 | -3.11 % | $ 52.2 M | USA |
 |
Fennec Pharmaceuticals
FENC
|
10.5 M | $ 10.12 | 0.4 % | $ 289 M | USA |
 |
Foghorn Therapeutics
FHTX
|
59.7 M | $ 2.04 | 2.0 % | $ 128 M | USA |
 |
Arcturus Therapeutics Holdings
ARCT
|
36.4 M | $ 9.91 | 0.71 % | $ 271 M | Israel |
 |
Arcutis Biotherapeutics
ARQT
|
130 M | $ 31.74 | 1.73 % | $ 4.04 B | USA |
 |
Geron Corporation
GERN
|
112 M | $ 1.15 | 2.23 % | $ 767 M | USA |
 |
Gossamer Bio
GOSS
|
63.4 M | $ 9.2 | -4.27 % | $ 2.1 B | USA |
 |
Titan Pharmaceuticals
TTNP
|
483 K | - | -3.76 % | $ 3.47 M | USA |
 |
Allena Pharmaceuticals
ALNA
|
15.7 M | - | 3.16 % | $ 1.9 M | USA |